Nektar Therapeutics
NKTR
S$30.42
Share price
-5.40%
Change (1 day)
1,565.27%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Cash on Hand
Cash on Hand as of March 2025 : S$0.28 Billion
According to Nektar Therapeutics
's latest financial reports the company has S$0.28 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nektar Therapeutics - Cash on Hand chart (from 1996 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$0.34 B | -13.48% |
| 2023-12-31 | S$0.40 B | -40.77% |
| 2022-12-31 | S$0.67 B | -31.77% |
| 2021-12-31 | S$0.99 B | -29.37% |
| 2020-12-31 | S$1.40 B | -21.35% |
| 2019-12-31 | S$1.78 B | -2.09% |
| 2018-12-31 | S$1.82 B | 360.59% |
| 2017-12-31 | S$0.39 B | -29.67% |
| 2016-12-31 | S$0.56 B | 28.86% |
| 2015-12-31 | S$0.43 B | 39.07% |
| 2014-12-31 | S$0.31 B | 4.64% |
| 2013-12-31 | S$0.30 B | -11.41% |
| 2012-12-31 | S$0.33 B | 8.53% |
| 2011-12-31 | S$0.31 B | -23.25% |
| 2010-12-31 | S$0.40 B | -26.84% |
| 2009-12-31 | S$0.55 B | 2.63% |
| 2008-12-31 | S$0.54 B | -21.91% |
| 2007-12-31 | S$0.69 B | -1.3% |
| 2006-12-31 | S$0.70 B | -11.3% |
| 2005-12-31 | S$0.79 B | 16.06% |
| 2004-12-31 | S$0.68 B | 40.6% |
| 2003-12-31 | S$0.48 B | -4.75% |
| 2002-12-31 | S$0.51 B | -19.98% |
| 2001-12-31 | S$0.63 B | -24.14% |
| 2000-12-31 | S$0.84 B | 265.22% |
| 1999-12-31 | S$0.23 B | 68.18% |
| 1998-12-31 | S$0.13 B | -19% |
| 1997-12-31 | S$0.16 B | 548.82% |
| 1996-12-31 | S$26.03 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | S$11.33 B | 3,929.60% | 🇺🇸 USA |
 Pfizer PFE | S$22.27 B | 7,820.16% | 🇺🇸 USA |
 Merck MRK | S$11.86 B | 4,120.79% | 🇺🇸 USA |
 Richardson Electronics RELL | S$47.16 M | -83.23% | 🇺🇸 USA |
 AstraZeneca AZN | S$6.93 B | 2,367.62% | 🇬🇧 UK |
 Baxter BAX | S$2.95 B | 949.25% | 🇺🇸 USA |
 Alkermes ALKS | S$1.13 B | 304.34% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | S$49.87 B | 17,638.03% | 🇺🇸 USA |